Dealmaking

Drug development: 10 PE-backed deals show interest in clinical trials

NMS Capital, QHP Capital, VSS Capital, and FFL Partners are some of the firms persuing opportunities in clinical trials.

Arctos Partners to invest in Aston Martin Aramco Cognizant F1 Team

Aston Martin Aramco Cognizant Formula One Team is a formula racing team.

NYSE’s Michael Harris shares insights on IPOs; Thoma Bravo in German take-private deal

The Riverside Company acquires Frenchies Modern Nail Care as an add-on in the firm's 50th franchise deal.

Primary Capital-backed Metamark snaps up Fleet Design

Fleet Design is an industrial markings producer.

NYSE's Michael Harris optimistic about IPOs in 2024

'There is a healthy pipeline of IPOs at the NYSE, among US and international issuers and across industry sectors. Private equity and VC-backed transactions continue to represent a meaningful portion of that backlog.'

The Riverside Company to announce 50th franchising acquisition

'There's a lot of private equity money that is pouring into the franchising space,' said Riverside's Grant Marcks.

MidEuropa on €1bn+ Profi sale and the exit market

Thoma Bravo in take-private bid for EQS.

MidEuropa beefed up digitalisation and logistics to position Romanian supermarket chain for sale

In October, MidEuropa announced it is selling Profi to Ahold Delhaize.

Azora picks up Planetocio leisure centre

Planetocio leisure centre is based in Madrid, Spain.

Kinetik to sell stake in GCX; Tim Short and Michael Hamilton launch Acadia

Ex-KKR Managing Director Short co-founds new energy transition investment firm.